Researchers from the University of Copenhagen and biotech firm Gubra have developed a new insulin molecule that will make blood sugar regulation both easier and safer for those with type 1 diabetes.
Everyday life for the more than 46 million people around the world who suffer from type 1 diabetes could become much easier and safer.
Researchers from the University of Copenhagen and biotech firm Gubra have developed a new insulin molecule that, in the future, will ensure that diabetics receive just the right amount of insulin.
The insulin on the market today is unable to identify whether a patient with type 1 diabetes needs a small or large effect from the insulin, which lowers blood sugar.
“That is why we have developed the first step towards a kind of insulin that can self-adjust according to a patient’s blood sugar level. This has tremendous potential to vastly improve the lives of people with type 1 diabetes,” explains Professor Knud J. Jensen, of the University of Copenhagen’s Department of Chemistry, one of the researchers behind a new study on this new insulin.
Effective in rats
The researchers behind the study developed a type of insulin with a built-in molecular-binding that can sense how much blood sugar is in the body. As blood sugar rises, the molecule becomes more active and releases more insulin. As blood sugar drops, less is released.
“The molecule constantly releases a small amount of insulin, but varies according to need,” says Knud J. Jensen, who continues:
“It will give type 1 diabetes patients a safer and easier treatment. Today, a person with type 1 diabetes must inject themselves with insulin many times throughout the day and frequently monitor their blood sugar level by pricking their finger with a blood glucose meter. This here, allows a person to inject the new insulin molecule less often over the course of a day and thereby think about it less,” says Knud J. Jensen.
Although the new ‘automated’ insulin is a major advance towards better diabetes treatment, it will be a while before the revolutionary insulin becomes a part of diabetics’ everyday lives.
“We’ve tested the insulin molecule on rats and it has proven itself effective. The next step is to develop the molecule so that it works more rapidly and accurately. And finally, to test it in humans — a process that can take many years. But it is certainly worth pinning one’s hopes on,” explains Professor Jensen.
An idea that sprouted in the United States
The idea to create a kind of insulin that self-adjusts to a patient’s needs occurred many years ago, while Professor Jensen was living in the United States. This is where a friend of his with type 1 diabetes recounted to him a story:
“My author friend Jan Sonnergaard told me about a married couple who had been dancing one night. The man had type 1 diabetes and was feeling unwell. The wife thought to stabilise his blood sugar by giving him insulin. Unfortunately, the insulin eventuated in her husband’s death. I wanted to make certain that this kind of tragedy would never be repeated,” says Knud J. Jensen, concluding:
“The difficult thing with diabetes is that insulin always works the same way. It lowers blood sugar, even though that might not be what a patient requires. This is what we seek to address with our new molecule.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Sterile Injectables Market Report 2021: Rising Impressive Business Opportunities Analysis Forecast By 2025on April 29, 2021 at 10:05 pm
According to Azoth Analytics research report "Global Sterile Injectables Market - Analysis By Molecule Type, Drug Type, Indication, Distribution Channel, By Region, By Country (2018 Edition): Forecast ...
- Tarantula venom shows promise as type 2 diabetes treatmenton April 29, 2021 at 4:01 pm
The poisonous substance 'contains millions of biologically active molecules that may have therapeutic potential'.
- Biopharmaceuticals Market to Reach USD 113,300 Million by 2026 at CAGR 4.7% - Valuates Reportson April 29, 2021 at 7:30 am
The Biopharmaceuticals Market is Segmented by Type (Monoclonal Antibodies, Interferon, Colony-Stimulating Factor, Erythropoietin, Insulin, Vaccines, Growth Hormones, Others), by Application (Tumor, ...
- Nitric Oxide and the Cell: Proliferation, Differentiation, and Deathon April 28, 2021 at 4:37 pm
Insulin and glucagon are secreted in a co-ordinated manner ... Bonfoco and S.A. Lipton Cellular apoptosis and necrosis have different defining morphological and molecular features and implications for ...
- Biovie resistance futile to insulin as Neurmedix’s next-generation AD approachon April 28, 2021 at 1:37 pm
Biovie Inc. Chairman Terren Peizer said Neurmedix Inc. “had been offered a better deal in the shorter term,” but the contract signed by the two firms – which installs entrepreneur Cuong Do the new CEO ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Blood sugar regulation
- Diabetes type 2 symptoms: Three sensations in your feet that indicate blood sugar damageon May 1, 2021 at 5:58 am
DIABETES type 2 is a chronic condition whereby blood sugar levels are in a state of flux. Consistently high blood sugar levels can inflict damage on the feet - here are three telltale signs.
- Exercise may attenuate faulty gene responsible for high blood sugar: Studyon April 30, 2021 at 11:15 pm
Denmark: One hour of daily exercise is sufficient to help control blood sugar levels in Arctic Inuit with a faulty copy of the TBC1D4 gene, which is responsible for an increased risk of type ...
- 6 healthy choices for blood sugar controlon April 30, 2021 at 10:15 pm
Lifestyle expert and type 1 diabetic Danica McAdam shares six products for snack time and blood sugar control. Sukrin USA carries a range of all-natural, zero-calorie, and low-carb sugar alternatives.
- Gluco Shield Pro Reviews - Customer Scam Complaints or Blood Sugar Ingredients Really Work?on April 30, 2021 at 2:14 pm
Gluco Shield Pro is a dietary supplement that helps regulate healthy blood sugar levels while targeting your body's insulin response. As mentioned on the official website, this product uses a blend of ...
- Glucofort Reviews: Negative Side Effects or Real Blood Sugar Pillson April 30, 2021 at 1:36 pm
Blood sugar issues have risen significantly in recent times. The effects of high or low blood sugar levels can be quite severe. These issues are caused by several medical or lifestyle factors, and ...